Netcall’s (NET) Buy Rating Reiterated at Berenberg Bank

Netcall (LON:NET)‘s stock had its “buy” rating reissued by investment analysts at Berenberg Bank in a research report issued on Wednesday,Digital Look reports. They currently have a GBX 165 price objective on the stock. Berenberg Bank’s target price points to a potential upside of 61.76% from the stock’s current price.

Separately, Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 160 target price on shares of Netcall in a research report on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Netcall currently has an average rating of “Buy” and an average price target of GBX 162.50.

Netcall Stock Performance

Shares of Netcall stock traded down GBX 1 during mid-day trading on Wednesday, hitting GBX 102. 393,725 shares of the stock were exchanged, compared to its average volume of 387,212. Netcall has a 12 month low of GBX 88 and a 12 month high of GBX 138. The company has a 50-day simple moving average of GBX 119.01 and a 200 day simple moving average of GBX 117.98. The company has a market capitalization of £173.89 million, a P/E ratio of 42.32 and a beta of 0.23. The company has a debt-to-equity ratio of 2.37, a quick ratio of 0.88 and a current ratio of 0.86.

Netcall (LON:NET) last released its earnings results on Wednesday, March 4th. The company reported GBX 2.43 earnings per share (EPS) for the quarter. Netcall had a return on equity of 9.39% and a net margin of 8.44%. Sell-side analysts anticipate that Netcall will post 3.7029017 earnings per share for the current fiscal year.

About Netcall

Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission‑critical workflows, including two‑thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.